Event name:
WHERE POPULATION-LEVEL HEALTH BENEFIT IS OFTEN FORGOTTEN: THE INDIVIDUAL JOURNEYS OF HEAVY, EXCLUSIVE SMOKERS SWITCHING TO GLAS AGE-GATED ENDS DEVICE IN A 3-MONTH SWITCHING STUDYSession Date:
September 18, 2025 –
Session Speakers:
DR. Jessica Zdinak - Applied Research and Analysis Company (ARAC)
- Purpose of Research
- FDA CTP deficiency response
- Candidate product benefit & APPH standard
- Going beyond the APPH standard & regulatory requirements
- The individual vs. the population
- Research Objectives, Methods, & Design
- Aggregate Population/Study Sample-Level Results
- Considering the Individual
